Galmed Pharmaceuticals (GLMD) has released an update.
Galmed Pharmaceuticals Ltd. successfully conducted its Annual General Meeting on July 17, 2024, where shareholders voted in favor of all proposed resolutions in alignment with Israeli Companies Law. The outcomes of the meeting, initially detailed in a June 5 report, have been formally integrated into the company’s SEC filings. This corporate update is set to have implications for Galmed’s investors and could influence the company’s stock performance.
For further insights into GLMD stock, check out TipRanks’ Stock Analysis page.
